1. Home
  2. ENOV vs BCAT Comparison

ENOV vs BCAT Comparison

Compare ENOV & BCAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENOV
  • BCAT
  • Stock Information
  • Founded
  • ENOV 1995
  • BCAT 2020
  • Country
  • ENOV United States
  • BCAT United States
  • Employees
  • ENOV N/A
  • BCAT N/A
  • Industry
  • ENOV Fluid Controls
  • BCAT Finance/Investors Services
  • Sector
  • ENOV Industrials
  • BCAT Finance
  • Exchange
  • ENOV Nasdaq
  • BCAT Nasdaq
  • Market Cap
  • ENOV 1.6B
  • BCAT 1.5B
  • IPO Year
  • ENOV 2008
  • BCAT N/A
  • Fundamental
  • Price
  • ENOV $28.45
  • BCAT $15.05
  • Analyst Decision
  • ENOV Strong Buy
  • BCAT
  • Analyst Count
  • ENOV 6
  • BCAT 0
  • Target Price
  • ENOV $51.00
  • BCAT N/A
  • AVG Volume (30 Days)
  • ENOV 1.6M
  • BCAT 308.8K
  • Earning Date
  • ENOV 08-07-2025
  • BCAT 01-01-0001
  • Dividend Yield
  • ENOV N/A
  • BCAT 9.38%
  • EPS Growth
  • ENOV N/A
  • BCAT N/A
  • EPS
  • ENOV N/A
  • BCAT 1.43
  • Revenue
  • ENOV $2,189,576,000.00
  • BCAT N/A
  • Revenue This Year
  • ENOV $8.23
  • BCAT N/A
  • Revenue Next Year
  • ENOV $6.18
  • BCAT N/A
  • P/E Ratio
  • ENOV N/A
  • BCAT $11.41
  • Revenue Growth
  • ENOV 14.40
  • BCAT N/A
  • 52 Week Low
  • ENOV $25.47
  • BCAT $13.67
  • 52 Week High
  • ENOV $49.83
  • BCAT $16.38
  • Technical
  • Relative Strength Index (RSI)
  • ENOV 48.56
  • BCAT 54.36
  • Support Level
  • ENOV $25.72
  • BCAT $14.71
  • Resistance Level
  • ENOV $29.56
  • BCAT $14.98
  • Average True Range (ATR)
  • ENOV 1.08
  • BCAT 0.11
  • MACD
  • ENOV 0.22
  • BCAT 0.01
  • Stochastic Oscillator
  • ENOV 72.86
  • BCAT 94.44

About ENOV Enovis Corporation

Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.

About BCAT BlackRock Capital Allocation Term Trust of Beneficial Interest

BlackRock Capital Allocation Trust is a non-diversified, closed-end management investment company. The investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation.

Share on Social Networks: